NIH-funded research R01 grant

A brief automated neurocognitive training to extend ketamine’s quick antidepressant effects

Official title: 1/2 A Brief Automated Neurocognitive Training to Enhance the Real-World Impact of Ketamine's Rapid Antidepressant Effect

Funded at University of Pittsburgh at Pittsburgh · NIH-11345783 · Data updated 2026-11-12

This project tests a digital cognitive training tool designed to prolong the mood benefits after an IV ketamine dose in people with depression.

More Ketamine research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Pittsburgh at Pittsburgh
NIH-funded
Lab location1 site (Pittsburgh, United States)
Project startJuly 5, 2024
Project endMay 31, 2029
Funding year2026
Award (this year)$968,785
NIH project number5R01MH136179-03
Project IDNIH-11345783 on NIH RePORTER

Who could benefit from this research

Could help

Adults with depression who are receiving ketamine treatment and willing to participate in digital cognitive training after infusion.

Less likely to help

Individuals not receiving ketamine or those unable to participate in digital training may not benefit.

What this research studies

This grant aims to pair a fast-acting ketamine treatment with a computerized self-association training to solidify positive self-views while the brain remains highly plastic. By delivering Automated Self Association Training soon after ketamine, researchers hope to extend the antidepressant window beyond the usual 1-2 weeks. The study will enroll adults with depression and follow them after infusion to see if the combined treatment yields longer-lasting mood improvements and cognitive changes. Outcomes will include depressive symptoms, cognitive processing, and safety, with emphasis on real-world applicability in community ketamine settings.

Why it matters

Potential benefit: If successful, patients could experience longer-lasting relief from depressive symptoms after ketamine, reducing relapse and the need for frequent dosing.

How similar studies have gone: Prior work suggests combining neuromodulation with cognitive training can extend treatment effects, but this specific ketamine + ASAT approach is innovative and evidence is developing.

Where this research is happening

  • University of Pittsburgh at Pittsburgh
    Pittsburgh, United States
    Active

Researchers

  • Principal investigator: Price, Rebecca — University of Pittsburgh at Pittsburgh
  • Study coordinator: Price, Rebecca

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.